Our first idea today is a medical device company that beat analysts’ estimates by $0.10 last quarter, and our second is a sale of a previous recommendation.
Edwards Lifesciences Corporation (EW)
From PAD System Report
We’re switching our Cerner Corporation money into Edwards Lifesciences Corporation (EW). Edwards is a health-care play with earnings that have been growing steadily for more than a decade. Wall Street knocked it down a bit recently even though earnings were good. And 3-5 year appreciation potential is as good as Cerner, year-ahead performance is better, and beta is lower.
Edwards’ big bet is on treatment for heart disease, which is unfortunately, a growing market.
Daniel A. Seiver, PAD System Report, www.padsystemreport.com, Dept. of Finance, S.D.S.U,
San Diego, CA 92181, August 25, 2018